AcelRx Pharma (ACRX)

2.90 +0.27 (10.27%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/8/18 *Est.)

Latest Headlines

Pre-Open Stock Movers 02/15: (TLND) (CBAY) (NVDA) Higher; (AKAO) (TRUE) (LOGM) Lower (more...) February 15, 2019 9:27 AM - StreetInsider Credit Suisse Starts AcelRx Pharmaceuticals (ACRX) at Outperform February 15, 2019 6:54 AM - StreetInsider Form 8-K ACELRX PHARMACEUTICALS For: Feb 10 February 14, 2019 6:14 PM - SEC Filing Form 4 ACELRX PHARMACEUTICALS For: Feb 11 Filed by: Hamel Lawrence G February 13, 2019 5:46 PM - SEC Filing Form 4 ACELRX PHARMACEUTICALS For: Feb 11 Filed by: Dasu Badri N February 13, 2019 5:45 PM - SEC Filing Form 4 ACELRX PHARMACEUTICALS For: Feb 11 Filed by: ASADORIAN RAFFI February 13, 2019 5:44 PM - SEC Filing Form 4 ACELRX PHARMACEUTICALS For: Feb 11 Filed by: Palmer Pamela P February 13, 2019 5:43 PM - SEC Filing Form 4 ACELRX PHARMACEUTICALS For: Feb 11 Filed by: Angotti Vincent J. February 13, 2019 5:41 PM - SEC Filing Hercules Capital Announces Multiple Outstanding Achievements by Numerous Investment Portfolio Companies February 12, 2019 6:00 AM - BizWire Form 5 ACELRX PHARMACEUTICALS For: Dec 31 Filed by: HOFFMAN STEPHEN J February 7, 2019 5:35 PM - SEC Filing AcelRx Pharmaceutical's sufentanil sublingual tablet (DSUVIA) to be highlighted during a presentation at the Boswick Burn and Wound Symposium January 31, 2019 7:01 AM - PR NewsWire Form 8-K ACELRX PHARMACEUTICALS For: Jan 08 January 11, 2019 4:32 PM - SEC Filing AcelRx Pharma (ACRX) Reports Publication of Pooled Data Analysis on Sufentanil Sublingual Tablets January 7, 2019 8:49 AM - StreetInsider AcelRx Pharmaceuticals announces publication analyzing pooled data on sufentanil sublingual tablets for short-term treatment of moderate-to-severe acute pain January 7, 2019 8:30 AM - PR NewsWire AcelRx Pharmaceuticals added to the NASDAQ Biotechnology Index (NBI) December 18, 2018 7:00 AM - PR NewsWire AcelRx Pharma (ACRX) Sees Insider Buys from CEO and CFO December 17, 2018 12:11 PM - StreetInsider Form 4 ACELRX PHARMACEUTICALS For: Dec 14 Filed by: Angotti Vincent J. December 17, 2018 12:06 PM - SEC Filing Form 4 ACELRX PHARMACEUTICALS For: Dec 14 Filed by: ASADORIAN RAFFI December 17, 2018 12:06 PM - SEC Filing AcelRx Pharma (ACRX) CEO Buys 10K Shares December 13, 2018 6:47 AM - StreetInsider Form 4 ACELRX PHARMACEUTICALS For: Dec 12 Filed by: Angotti Vincent J. December 12, 2018 7:32 PM - SEC Filing AcelRx Pharmaceuticals to Host Analyst and Investor Day on December 11 November 29, 2018 4:35 PM - PR NewsWire Form 4 ACELRX PHARMACEUTICALS For: Nov 19 Filed by: Palmer Pamela P November 19, 2018 6:14 PM - SEC Filing Full Article List